News
1h
Zacks Investment Research on MSNWill Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
The global prevalence of OA attributed to high BMI has steadily increased over the past 3 decades, particularly among women and in high-SDI regions.
1d
Zacks Investment Research on MSNHere's How Lilly's Non-Obesity Drugs are Contributing to Sales GrowthWhile Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for type II diabetes) and Zepbound (for obesity) — which accounted for 48% of ...
A new study compares body mass index (BMI) with body fat percentage and finds the latter is far more reliable in predicting ...
A new study from US scientists has predicted a huge increase in this killer cancer-and there's one group in particular at ...
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results